Alzheimer’s Disease (2015)
Alzheimer's disease is the sixth leading cause of death in the United States, impacting an estimated 5.3 million Americans. Despite widespread research into treatments for Alzheimer's disease, there is a staggering 99.6% failure rate in clinical trials to bring new treatments to market.
Allen Distinguished Investigator (ADI) grants were given to five teams of researchers with projects that will open new and innovative avenues of research in Alzheimer's disease by uncovering its elusive biological roots. The projects are funded at a total of $7 million over three years.
Affiliated Investigators
Affiliated Projects
Alzheimer’s Disease (2015)
Dysregulation of pH dynamics in Alzheimer Disease Pathogenesis
Alzheimer’s Disease (2015)
Human age-equivalent directly induced neurons to study functional phenotypes of Alzheimer’s disease.
Alzheimer’s Disease (2015)
Resolving white matter dysfunction in Alzheimer's disease with novel biosensors
Alzheimer’s Disease (2015)
Systematic elucidation of cellular networks controlling proteinopathy in Alzheimer’s disease